[1]
Y. Fan, “Application of CRISPR/Cas9 Gene Editing Technology in Targeted Therapy of Alzheimer’s Disease”, HSET, vol. 153, pp. 410–414, Sep. 2025, doi: 10.54097/x8m0p842.